Antiulcerant Drugs Market Dynamics, Growth, and Opportunities 2031
Antiulcerant Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Proton pump inhibitors, H2 receptor antagonists, Antibiotics, Gastric mucosal protective drugs, Antacids, Prostaglandin agonists); Disease (Stomach Ulcers, Leg Ulcers, Peptic Ulcers, Esophageal Ulcer, Bleeding Ulcer, Refractory Ulcer, Stress Ulcer, Mouth Ulcers, Venous Stasis Ulcers, Neuropathic Ulcers, Arterial Ulcers, Pressure Ulcers) , and Geography (North America, Europe, Asia Pacific, and South and Central America)
- Status : Data Released
- Report Code : TIPRE00003747
- Category : Life Sciences
- No. of Pages : 150
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Antiulcerant Drugs Market is estimated to witness a CAGR of 4.4% from 2025 to 2031.
The major factors driving the antiulcerant drugs market are the increasing prevalence of gastric disorders, advancements in drug formulations and delivery systems, and rising demand for over-the-counter (OTC) antiulcerant drugs.
Future trends in the Antiulcerant Drugs Market are Growth of Biologic Antiulcerant Drugs, Integration of Digital Health and Telemedicine for Treatment Monitoring, Rise in Natural and Herbal Antiulcerant Drugs.
Some of the players operating in the market are Dr. Reddy's Laboratories, Ltd, Cipla, Glenmark, Aristo Pharma, Takeda Pharmaceutical Company Limited, Salix Pharmaceuticals, Zydus Cadila, Pfizer, Inc, Fourrts Himalaya Wellness Company.
The report can be delivered in PDF/PPT format; we can also share an excel datasheet based on the request.
Some customization options available based on the request are an additional 35 company profiles and a country-specific analysis of 35 countries of your choice. Customizations are to be requested/discussed before making final order confirmation# as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antiulcerant Drugs Market - By Type
1.3.2 Antiulcerant Drugs Market - By Disease
1.3.3 Antiulcerant Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIULCERANT DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. ANTIULCERANT DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIULCERANT DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIULCERANT DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTIULCERANT DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIULCERANT DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PROTON PUMP INHIBITORS
7.3.1. Overview
7.3.2. Proton pump inhibitors Market Forecast and Analysis
7.4. H2 RECEPTOR ANTAGONISTS
7.4.1. Overview
7.4.2. H2 receptor antagonists Market Forecast and Analysis
7.5. ANTIBIOTICS
7.5.1. Overview
7.5.2. Antibiotics Market Forecast and Analysis
7.6. GASTRIC MUCOSAL PROTECTIVE DRUGS
7.6.1. Overview
7.6.2. Gastric mucosal protective drugs Market Forecast and Analysis
7.7. ANTACIDS
7.7.1. Overview
7.7.2. Antacids Market Forecast and Analysis
7.8. PROSTAGLANDIN AGONISTS
7.8.1. Overview
7.8.2. Prostaglandin agonists Market Forecast and Analysis
8. ANTIULCERANT DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE
8.1. OVERVIEW
8.2. DISEASE MARKET FORECASTS AND ANALYSIS
8.3. STOMACH ULCERS
8.3.1. Overview
8.3.2. Stomach Ulcers Market Forecast and Analysis
8.4. LEG ULCERS
8.4.1. Overview
8.4.2. Leg Ulcers Market Forecast and Analysis
8.5. PEPTIC ULCERS
8.5.1. Overview
8.5.2. Peptic Ulcers Market Forecast and Analysis
8.6. ESOPHAGEAL ULCER
8.6.1. Overview
8.6.2. Esophageal Ulcer Market Forecast and Analysis
8.7. BLEEDING ULCER
8.7.1. Overview
8.7.2. Bleeding Ulcer Market Forecast and Analysis
8.8. REFRACTORY ULCER
8.8.1. Overview
8.8.2. Refractory Ulcer Market Forecast and Analysis
8.9. STRESS ULCER
8.9.1. Overview
8.9.2. Stress Ulcer Market Forecast and Analysis
8.10. MOUTH ULCERS
8.10.1. Overview
8.10.2. Mouth Ulcers Market Forecast and Analysis
8.11. VENOUS STASIS ULCERS
8.11.1. Overview
8.11.2. Venous Stasis Ulcers Market Forecast and Analysis
8.12. NEUROPATHIC ULCERS
8.12.1. Overview
8.12.2. Neuropathic Ulcers Market Forecast and Analysis
8.13. ARTERIAL ULCERS
8.13.1. Overview
8.13.2. Arterial Ulcers Market Forecast and Analysis
8.14. PRESSURE ULCERS
8.14.1. Overview
8.14.2. Pressure Ulcers Market Forecast and Analysis
9. ANTIULCERANT DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Antiulcerant Drugs Market Overview
9.1.2 North America Antiulcerant Drugs Market Forecasts and Analysis
9.1.3 North America Antiulcerant Drugs Market Forecasts and Analysis - By Type
9.1.4 North America Antiulcerant Drugs Market Forecasts and Analysis - By Disease
9.1.5 North America Antiulcerant Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Antiulcerant Drugs Market
9.1.5.1.1 United States Antiulcerant Drugs Market by Type
9.1.5.1.2 United States Antiulcerant Drugs Market by Disease
9.1.5.2 Canada Antiulcerant Drugs Market
9.1.5.2.1 Canada Antiulcerant Drugs Market by Type
9.1.5.2.2 Canada Antiulcerant Drugs Market by Disease
9.1.5.3 Mexico Antiulcerant Drugs Market
9.1.5.3.1 Mexico Antiulcerant Drugs Market by Type
9.1.5.3.2 Mexico Antiulcerant Drugs Market by Disease
9.2. EUROPE
9.2.1 Europe Antiulcerant Drugs Market Overview
9.2.2 Europe Antiulcerant Drugs Market Forecasts and Analysis
9.2.3 Europe Antiulcerant Drugs Market Forecasts and Analysis - By Type
9.2.4 Europe Antiulcerant Drugs Market Forecasts and Analysis - By Disease
9.2.5 Europe Antiulcerant Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Antiulcerant Drugs Market
9.2.5.1.1 Germany Antiulcerant Drugs Market by Type
9.2.5.1.2 Germany Antiulcerant Drugs Market by Disease
9.2.5.2 France Antiulcerant Drugs Market
9.2.5.2.1 France Antiulcerant Drugs Market by Type
9.2.5.2.2 France Antiulcerant Drugs Market by Disease
9.2.5.3 Italy Antiulcerant Drugs Market
9.2.5.3.1 Italy Antiulcerant Drugs Market by Type
9.2.5.3.2 Italy Antiulcerant Drugs Market by Disease
9.2.5.4 Spain Antiulcerant Drugs Market
9.2.5.4.1 Spain Antiulcerant Drugs Market by Type
9.2.5.4.2 Spain Antiulcerant Drugs Market by Disease
9.2.5.5 United Kingdom Antiulcerant Drugs Market
9.2.5.5.1 United Kingdom Antiulcerant Drugs Market by Type
9.2.5.5.2 United Kingdom Antiulcerant Drugs Market by Disease
9.2.5.6 Rest of Europe Antiulcerant Drugs Market
9.2.5.6.1 Rest of Europe Antiulcerant Drugs Market by Type
9.2.5.6.2 Rest of Europe Antiulcerant Drugs Market by Disease
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Antiulcerant Drugs Market Overview
9.3.2 Asia-Pacific Antiulcerant Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Antiulcerant Drugs Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Antiulcerant Drugs Market Forecasts and Analysis - By Disease
9.3.5 Asia-Pacific Antiulcerant Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Antiulcerant Drugs Market
9.3.5.1.1 Australia Antiulcerant Drugs Market by Type
9.3.5.1.2 Australia Antiulcerant Drugs Market by Disease
9.3.5.2 China Antiulcerant Drugs Market
9.3.5.2.1 China Antiulcerant Drugs Market by Type
9.3.5.2.2 China Antiulcerant Drugs Market by Disease
9.3.5.3 India Antiulcerant Drugs Market
9.3.5.3.1 India Antiulcerant Drugs Market by Type
9.3.5.3.2 India Antiulcerant Drugs Market by Disease
9.3.5.4 Japan Antiulcerant Drugs Market
9.3.5.4.1 Japan Antiulcerant Drugs Market by Type
9.3.5.4.2 Japan Antiulcerant Drugs Market by Disease
9.3.5.5 Rest of Asia-Pacific Antiulcerant Drugs Market
9.3.5.5.1 Rest of Asia-Pacific Antiulcerant Drugs Market by Type
9.3.5.5.2 Rest of Asia-Pacific Antiulcerant Drugs Market by Disease
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Antiulcerant Drugs Market Overview
9.4.2 Middle East and Africa Antiulcerant Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Antiulcerant Drugs Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Antiulcerant Drugs Market Forecasts and Analysis - By Disease
9.4.5 Middle East and Africa Antiulcerant Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Antiulcerant Drugs Market
9.4.5.1.1 South Africa Antiulcerant Drugs Market by Type
9.4.5.1.2 South Africa Antiulcerant Drugs Market by Disease
9.4.5.2 U.A.E Antiulcerant Drugs Market
9.4.5.2.1 U.A.E Antiulcerant Drugs Market by Type
9.4.5.2.2 U.A.E Antiulcerant Drugs Market by Disease
9.4.5.3 Rest of Middle East and Africa Antiulcerant Drugs Market
9.4.5.3.1 Rest of Middle East and Africa Antiulcerant Drugs Market by Type
9.4.5.3.2 Rest of Middle East and Africa Antiulcerant Drugs Market by Disease
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Antiulcerant Drugs Market Overview
9.5.2 South and Central America Antiulcerant Drugs Market Forecasts and Analysis
9.5.3 South and Central America Antiulcerant Drugs Market Forecasts and Analysis - By Type
9.5.4 South and Central America Antiulcerant Drugs Market Forecasts and Analysis - By Disease
9.5.5 South and Central America Antiulcerant Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Antiulcerant Drugs Market
9.5.5.1.1 Brazil Antiulcerant Drugs Market by Type
9.5.5.1.2 Brazil Antiulcerant Drugs Market by Disease
9.5.5.2 Argentina Antiulcerant Drugs Market
9.5.5.2.1 Argentina Antiulcerant Drugs Market by Type
9.5.5.2.2 Argentina Antiulcerant Drugs Market by Disease
9.5.5.3 Rest of South and Central America Antiulcerant Drugs Market
9.5.5.3.1 Rest of South and Central America Antiulcerant Drugs Market by Type
9.5.5.3.2 Rest of South and Central America Antiulcerant Drugs Market by Disease
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ANTIULCERANT DRUGS MARKET, KEY COMPANY PROFILES
11.1. DR. REDDY'S LABORATORIES, LTD
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. CIPLA
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GLENMARK
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ARISTO PHARMA
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. TAKEDA PHARMACEUTICAL COMPANY LIMITED
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. SALIX PHARMACEUTICALS
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ZYDUS CADILA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER, INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. FOURRTS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. HIMALAYA WELLNESS COMPANY
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
"
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For